首页 / 产品 / 抗体 / 一抗

Rabbit Polyclonal EphrinB1/B2/B3(phosphoY324/Y311/Y318) Antibody

  • 中文名: Ephrin B1/B2/B3 (phospho Y324/Y311/Y318)抗体
  • 别    名: EPL2; CEL5-L; EFL-3; EFNB1; ELK-L
货号: IPDX40480
Price: ¥1280
数量:
大包装询价

验证与应用

应用及物种
WB 咨询技术 Human,Mouse,Rat
IF 咨询技术 Human,Mouse,Rat
IHC 1/50-1/100 Human,Mouse,Rat
ICC 技术咨询 Human,Mouse,Rat
FCM 咨询技术 Human,Mouse,Rat
Elisa 咨询技术 Human,Mouse,Rat

产品详情

AliasesEPL2; CEL5-L; EFL-3;  EFNB1;  ELK-L
Entrez GeneID1947;
WB Predicted band size46kDa
Host/IsotypeRabbit IgG
Antibody TypePrimary antibody
StorageStore at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles.
Species ReactivityHuman
ImmunogenPeptide sequence around phosphorylation site of tyrosine 324/311/318 (G-D-Y(p)-G-H)  derived from Human Ephrin B1/B2/B3 .
FormulationPurified antibody in PBS with 0.05% sodium azide.

+ +

参考文献

以下是关于Ephrin B1/B2/B3 (phospho Y324/Y311/Y318)抗体的参考文献示例(内容为模拟虚构,供参考):

1. **文献名称**:*Ephrin-B Phosphorylation Regulates Reverse Signaling in Axon Guidance*

**作者**:Smith A, et al.

**摘要**:研究揭示了Ephrin-B1/B2/B3在神经元轴突导向中的反向信号作用,通过Y324/Y311/Y318位点的磷酸化调控下游效应分子(如PDZ结构域蛋白),并利用特异性磷酸化抗体验证了其与细胞骨架重组的关联。

2. **文献名称**:*Tyrosine Phosphorylation of Ephrin-B Ligands Modulates Vascular Development*

**作者**:Chen L, et al.

**摘要**:探讨了Ephrin-B2 Y311磷酸化在内皮细胞血管生成中的作用,通过磷酸化特异性抗体发现其与VEGF信号协同调控血管分支,并证实该位点突变导致小鼠胚胎血管发育缺陷。

3. **文献名称**:*Ephrin-B3 Phosphorylation at Y318 Mediates Tumor Microenvironment Crosstalk*

**作者**:Wang X, et al.

**摘要**:利用Y318磷酸化抗体揭示Ephrin-B3在肿瘤基质细胞中的激活机制,表明其通过ERK通路促进癌细胞侵袭,为靶向磷酸化信号的治疗策略提供依据。

4. **文献名称**:*Cross-talk Between Ephrin-B Receptors and Phosphorylation-dependent Signaling Networks*

**作者**:Johnson R, et al.

**摘要**:系统分析了Ephrin-B1/B2/B3的酪氨酸磷酸化位点(Y324/Y311/Y318)在跨膜信号传导中的作用,结合抗体实验证明其与Src激酶及STAT3通路的相互作用,影响细胞迁移与分化。

(注:以上文献为示例性内容,实际引用需检索PubMed等数据库获取真实文献。)

背景信息

The Ephrin B1/B2/B3 (phospho Y324/Y311/Y318) antibody detects site-specific phosphorylation of Ephrin B family transmembrane ligands, which play critical roles in bidirectional cell signaling through interactions with Eph receptor tyrosine kinases. Ephrin B proteins (B1. B2. B3) share a conserved cytoplasmic domain containing tyrosine residues (Y324 in B1. Y311 in B2. Y318 in B3) that undergo phosphorylation to mediate "reverse signaling." These phosphorylated tyrosines serve as docking sites for SH2 domain-containing adaptor proteins, such as Grb4. facilitating downstream pathways like Rho GTPase, MAPK, and cytoskeletal remodeling. This signaling regulates cell-cell communication, migration, and tissue morphogenesis during neurodevelopment, angiogenesis, and tumor progression. Phosphorylation is triggered by Eph receptor engagement or crosstalk with other kinases (e.g., Src). The antibody specifically recognizes phosphorylated forms of all three Ephrin B isoforms, enabling researchers to study their activation dynamics in contexts like neural connectivity, vascular patterning, or cancer metastasis. Applications include Western blotting, immunofluorescence, and investigating therapeutic targets for diseases involving dysregulated Ephrin-Eph signaling. Validation requires controls like dephosphorylation treatments or non-phosphorylated peptide competition to confirm specificity, as phosphorylation is transient and context-dependent.

客户数据及评论

折叠内容

大包装询价

×